Medscape Podcasts

Keeping Current

Health EN ↓ 612 episodes

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Author

Medscape Podcasts

Episodes

The Importance of Maintaining Respiratory Syncytial Virus Protection in At-Risk Infants via Passive Immunization 05.12.2023 31:28

The Importance of Maintaining Respiratory Syncytial Virus Protection in At-Risk Infants via Passive Immunization Credit available for this activity expires: 12/04/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998878?ecd=bdc_podcast_libsyn_mscpedu

Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis 04.12.2023 33:16

Do you know what the consequences are of spondyloarthrtitis left untreated? Learn from our experts. Credit available for this activity expires: 11/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998875?ecd=bdc_podcast_libsyn_mscpedu

Testing and Timing for COVID-19 Therapies: Understanding Factors for Optimization 29.11.2023 18:25

Do you know the optimal time to start antiviral therapy for COVID-19? Credit available for this activity expires: 11/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998799?ecd=bdc_podcast_libsyn_mscpedu

Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates 27.11.2023 1:11:01

Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer? Credit available for this activity expires: 11/20/23 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998605?ecd=bdc_podcast_libsyn_mscpedu

Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy 23.11.2023 48:52

The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date? Credit available for this activity expires: 22/11/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998570?ecd=bdc_podcast_libsyn_mscpedu

Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Multidisciplinary Perspectives on Managing and Maximizing Care 16.11.2023 36:27

Do you know how adverse events (AEs) associated with Bruton tyrosine kinase (BTK) inhibitors affect patients' lives and how best to manage these events? Credit available for this activity expires: 11/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998369?ecd=bdc_podcast_libsyn_mscpedu

Diabetes Dialogue: Can We Reduce the Disease Burden with Weekly Basal Insulin? 14.11.2023 18:52

Did you know that adding basal insulin to patients who remain above target despite an optimal guideline-recommended antidiabetes regimen can further reduce HbA1c levels by up to 3 percentage points? Credit available for this activity expires: 11/14/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998367?ecd=bdc_podcast_libsyn_mscpedu

Understanding the Role of Biologics in Hidradenitis Suppurativa: A Journal Club Review of Recent Data and Clinical Impacts 09.11.2023 31:44

Are you up to date on the latest clinical trial data on biologic therapy in hidradenitis suppurativa (HS)? Credit available for this activity expires: 10/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997905?ecd=bdc_podcast_libsyn_mscpedu

The Evolving Treatment Landscape for Patients With Psoriatic Disease 08.11.2023 34:54

Did you know that in ~85% of patients with psoriasis (PsO), PsO precedes the onset of psoriatic arthritis (PsA)? Credit available for this activity expires: 11/07/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998077 ?ecd=bdc_podcast_libsyn_mscpedu

Value of Influenza Vaccination in Children: Impact on Transmission and Burden in the Whole Population 01.11.2023 33:51

Did you know that children are the main disseminators of influenza in the households and in the community? Credit available for this activity expires: 10/31/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997863?ecd=bdc_podcast_libsyn_mscpedu

Neurocognitive Disorders in People Living With HIV: Cause and Consequence 31.10.2023 35:46

Do you know the characteristics of cognitive disorders in people who are HIV positive? Do you know the pathogenesis of this neurocognitive decline? Credit available for this activity expires: 10/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997643?ecd=bdc_podcast_libsyn_mscpedu

New Therapies for Neovascular AMD and DME: What Have We Learned? 31.10.2023 28:28

Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu

Identifying Progressive Pulmonary Fibrosis on Imaging and Collaborating With the Multidisciplinary Team 30.10.2023 38:19

Do you know which high-resolution computed tomography (HRCT) patterns are associated with fibrosing interstitial lung disease and its progression? Credit available for this activity expires: 10/24/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/995581?ecd=bdc_podcast_libsyn_mscpedu

Demystifying Drug-Drug Interactions for COVID-19 Antivirals 23.10.2023 32:18

Find out from expert Dr Saye Khoo how to manage COVID-19 drug-drug interactions (DDIs). Credit available for this activity expires: 10/20/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997480?ecd=bdc_podcast_libsyn_mscpedu

CD19-Targeting in Relapsed/Refractory DLBCL: Optimizing the Use of Noncellular Therapies 23.10.2023 27:20

Did you know that noncellular CD19-targeted therapies represent a new therapeutic option in both transplant eligible and ineligible relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)? Credit available for this activity expires: 10/18/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997427?ecd=bdc_podcast_libsyn_mscpedu

Clinical Context of the Consensus: A Review of the Latest Recommendations for Waldenström Macroglobulinemia 17.10.2023 34:26

Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors? Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997311?ecd=bdc_podcast_libsyn_mscpedu

Dengue Vaccination in Endemic Populations: Implementation Strategies in Diverse Settings 11.10.2023 30:42

Do you know who should be prioritized for dengue vaccination in different settings? Credit available for this activity expires: 10/9/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997102?ecd=bdc_podcast_libsyn_mscpedu

When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend 29.09.2023 31:24

Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF). Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_p...

Epilepsy and Depression: Managing Common Situations 29.09.2023 15:51

Expert tips to better select treatments, implement, and talk with patients. Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996660?ecd=bdc_podcast_libsyn_mscpedu

Neprilysin Inhibition: In Heart Failure and Beyond 29.09.2023 35:09

Do you know about the extra cardiac effects and other effects of angiotensin receptor-neprilysin inhibitors (ARNIs)? Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996323?ecd=bdc_podcast_libsyn_mscpedu

What Are the Patients' Unmet Needs in C3 Glomerulopathy? Clinical Pearls on Current Management and Future Perspectives 29.09.2023 38:25

Do you know what the challenges are for patients and clinicians when managing C3 glomerulopathy, and what the role of emerging therapies is? Credit available for this activity expires: 9/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996820?ecd=bdc_podcast_libsyn_mscpedu

Hot Topics in Breast Cancer Clinical Research: Challenges, Opportunities, and Implications for Practice 28.09.2023 15:47

How up to date is your knowledge of ongoing clinical trials in breast cancer? Ready to absorb new data releases at upcoming Autumn meetings? Credit available for this activity expires: 9/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996833?ecd=bdc_podcast_libsyn_mscpedu

Optimizing Immunotherapy Combination Strategies for Metastatic NSCLC: From Evidence to Practice 28.09.2023 36:29

Are you choosing the right immunotherapy-based combination for the right patient? Watch this program to get clinical updates and expert insights. Credit available for this activity expires: 9/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996823?ecd=bdc_podcast_libsyn_mscpedu

Biosimilars 101: From Neurologists, for Neurologists 28.09.2023 37:52

Did you know that a biologic drug can undergo hundreds of authorized changes in its lifetime? Credit available for this activity expires: 9/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996834?ecd=bdc_podcast_libsyn_mscpedu

Diabetes Dialogue: Breaking Down Barriers to the Early Use of GLP-1 RAs in Primary Care 22.09.2023 15:58

Did you know therapeutic inertia is a key driver of uncontrolled type 2 diabetes? Credit available for this activity expires: 9/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996617?ecd=bdc_podcast_libsyn_mscpedu